ATE536873T1 - Feste orale formen von ebastin - Google Patents
Feste orale formen von ebastinInfo
- Publication number
- ATE536873T1 ATE536873T1 AT06830886T AT06830886T ATE536873T1 AT E536873 T1 ATE536873 T1 AT E536873T1 AT 06830886 T AT06830886 T AT 06830886T AT 06830886 T AT06830886 T AT 06830886T AT E536873 T1 ATE536873 T1 AT E536873T1
- Authority
- AT
- Austria
- Prior art keywords
- solid oral
- ebastin
- oral forms
- ebastine
- relates
- Prior art date
Links
- MJJALKDDGIKVBE-UHFFFAOYSA-N ebastine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)CCCN1CCC(OC(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 MJJALKDDGIKVBE-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001971 ebastine Drugs 0.000 title abstract 3
- 239000007787 solid Substances 0.000 title abstract 3
- 239000006185 dispersion Substances 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200502686A ES2277767B1 (es) | 2005-11-04 | 2005-11-04 | Formas orales solidas de ebastina. |
PCT/ES2006/000581 WO2007051877A1 (es) | 2005-11-04 | 2006-10-20 | Formas orales sólidas de ebastina |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE536873T1 true ATE536873T1 (de) | 2011-12-15 |
Family
ID=38005462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06830886T ATE536873T1 (de) | 2005-11-04 | 2006-10-20 | Feste orale formen von ebastin |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090304791A1 (de) |
EP (1) | EP1944028B1 (de) |
AT (1) | ATE536873T1 (de) |
ES (2) | ES2277767B1 (de) |
PT (1) | PT1944028E (de) |
WO (1) | WO2007051877A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201113266A (en) * | 2009-09-02 | 2011-04-16 | Ziopharm Oncology Inc | Pharmaceutical formulations for indibulin |
EP2589376B1 (de) | 2011-11-01 | 2016-09-21 | Inopharm Limited | Im Mund zerfallende Zusammensetzung aus Anti-Histamin-Wirkstoffen |
CN105326802A (zh) * | 2015-09-01 | 2016-02-17 | 杭州澳医保灵药业有限公司 | 一种依巴斯汀分散片及其制备方法 |
US20210161824A1 (en) * | 2019-03-12 | 2021-06-03 | Balto Therapeutics | Orally disintegrating tablets comprising glycopyrrolate and methods for increasing bioavailability |
CN114712322A (zh) * | 2022-04-01 | 2022-07-08 | 南京联智医药科技有限公司 | 一种依巴斯汀的盐的片剂及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2684298B1 (fr) * | 1991-12-03 | 1994-03-11 | Rhone Poulenc Rorer Sa | Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4. |
CN1190187C (zh) * | 1997-10-27 | 2005-02-23 | 默克专利股份有限公司 | 差水溶性药物的固态溶液和分散液 |
US20030026834A1 (en) * | 2001-04-10 | 2003-02-06 | Fahkreddin Jamali | NSAIDs composition containing tartaric acid |
WO2004069157A2 (en) * | 2003-01-17 | 2004-08-19 | Ophthalmic Research Associates, Inc. | Combinational use of long-acting and short-acting anti-histamines for ocular allergies |
EP1750717B1 (de) * | 2004-02-11 | 2017-07-19 | Rubicon Research Private Limited | Pharmazeutische zusammensetzungen mit kontrollierter freisetzung und verbesserter bioverfügbarkeit |
-
2005
- 2005-11-04 ES ES200502686A patent/ES2277767B1/es not_active Expired - Fee Related
-
2006
- 2006-10-20 ES ES06830886T patent/ES2380229T3/es active Active
- 2006-10-20 AT AT06830886T patent/ATE536873T1/de active
- 2006-10-20 US US12/092,477 patent/US20090304791A1/en not_active Abandoned
- 2006-10-20 PT PT06830886T patent/PT1944028E/pt unknown
- 2006-10-20 EP EP06830886A patent/EP1944028B1/de active Active
- 2006-10-20 WO PCT/ES2006/000581 patent/WO2007051877A1/es active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ES2380229T3 (es) | 2012-05-09 |
EP1944028B1 (de) | 2011-12-14 |
PT1944028E (pt) | 2012-03-22 |
ES2277767A1 (es) | 2007-07-16 |
EP1944028A1 (de) | 2008-07-16 |
ES2277767B1 (es) | 2008-04-01 |
WO2007051877A1 (es) | 2007-05-10 |
US20090304791A1 (en) | 2009-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1845954T3 (da) | Oralt opløsende sammensætning af olanzapin og donepzil | |
CY2016024I1 (el) | ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ | |
CY1117164T1 (el) | Φαρμακευτικες συνθεσεις περιλαμβανουσες κολλοειδες διοξειδιο πυριτιου | |
ATE451381T1 (de) | Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen | |
DK1445302T3 (da) | Detergentsammensætninger | |
CY1112401T1 (el) | Παραγωγα πυριδαζινης | |
ATE463495T1 (de) | Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten | |
ITRM20010464A1 (it) | Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica. | |
WO2006100081A3 (de) | Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung | |
NO20071476L (no) | Antidiuretiske midler. | |
JO3219B1 (ar) | صيغ جسم مضاد لـ cd20 | |
SI3219705T1 (sl) | Farmacevtski sestavki amorfne oblike N-(2,4-bis(1,1-dimetiletil)-5- hidroksifenil)-1,4-dihidro-4-oksokinolin-3-karboksamid | |
MX2007010414A (es) | Derivados de piridin-2-carboxamida como antagonistas de mglur5. | |
WO2007071915A3 (en) | Pharmaceutical product comprising porous silicon | |
EA200701687A1 (ru) | Гидрохлорид аморфного лерканидипина | |
EA200601596A1 (ru) | Улучшенный состав 6-меркаптопурина | |
MY140739A (en) | 2, 6-quinolinyl derivatives, processes for preparing them and their uses | |
ATE536873T1 (de) | Feste orale formen von ebastin | |
WO2007011878A8 (en) | Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists | |
IL227565A (en) | Salts of hexahydropananthridine preserved in position 5 of the heterocyclic group and pharmaceutical preparations containing them | |
CY1113257T1 (el) | Παραγωγα βενζυλοπιπεραζινης τα οποια ειναι χρησιμα στη θεραπεια γαστρεντερικων διαταραχων | |
AR054771A1 (es) | Composicion blanqueadora | |
ATE432335T1 (de) | Weichspülmittel | |
TW200640860A (en) | Lercanidipine free base | |
NO20064114L (no) | Fremgangsmate for fremstilling av N-arylpiperazinderivater |